RxDoctor Payments Data

Doris Ansah

Psychiatric/Mental Health · Laurel, MDNPI 1285391136

Payments from drug & device makers

$1,083in general payments, 2019–2025

Across 45 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$288
  • AbbVie$253
  • Vanda Pharmaceuticals Inc.$225
  • Neurocrine Biosciences, Inc.$81
  • Lundbeck LLC$75
  • Teva Pharmaceuticals USA, Inc.$62
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$1,083100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,083 in reported general payments places this provider in the 75th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$117,954
Medicare patients
467
Services billed
1,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sertraline Hcl212$4,815
Ramelteon41$4,755
Gabapentin193$4,085
Buspirone Hcl127$3,167
JanuviaSitagliptin Phosphate11$3,140
Mirtazapine111$2,787
Risperidone135$2,516
Divalproex Sodium53$2,307
Fluoxetine Hcl42$1,984
Aripiprazole26$1,809
Escitalopram Oxalate95$1,782
Duloxetine Hcl45$1,619
Bupropion XlBupropion Hcl38$951
Quetiapine Fumarate59$944
Trazodone Hcl66$850

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$27$4,815212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Laurel

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →